AC102-Suspension 12 mg/ml clinical trials

Phase II, Multi-Center, Randomized, Blinded Study Evaluating the Efficacy, Safety and Tolerability of a Single Intratympanic Dose of AC102 Compared to Oral Steroids for the Treatment of Idiopathic Sudden Sensorineural Hearing Loss

This study is looking at a new ear treatment, AC102, for sudden hearing loss. It compares AC102 given as a shot into the ear, to steroid tablets, to see which works better and is safer for improving hearing.